Disturbed expression of phase I and phase II estrogen-metabolizing enzymes in endometrial cancer: lower levels of CYP1B1 and increased expression of S-COMT.
- DOI
- 10.1016/j.mce.2010.09.011
- Published
- 2011 Jan 1
- Container
- Molecular and cellular endocrinology
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.mce.2010.09.011,
title = {Disturbed expression of phase I and phase II estrogen-metabolizing enzymes in endometrial cancer: lower levels of CYP1B1 and increased expression of S-COMT.},
author = {Hevir N and Sinkovec J and Rižner TL},
year = {2011},
journal = {Molecular and cellular endocrinology},
doi = {10.1016/j.mce.2010.09.011},
url = {https://doi.org/10.1016/j.mce.2010.09.011}
}RIS
TY - JOUR TI - Disturbed expression of phase I and phase II estrogen-metabolizing enzymes in endometrial cancer: lower levels of CYP1B1 and increased expression of S-COMT. AU - Hevir N AU - Sinkovec J AU - Rižner TL PY - 2011 JO - Molecular and cellular endocrinology DO - 10.1016/j.mce.2010.09.011 UR - https://doi.org/10.1016/j.mce.2010.09.011 ER -
APA
N, H., J, S., & TL, R. (2011). Disturbed expression of phase I and phase II estrogen-metabolizing enzymes in endometrial cancer: lower levels of CYP1B1 and increased expression of S-COMT.. Molecular and cellular endocrinology. https://doi.org/10.1016/j.mce.2010.09.011
Source records
- pubmed · retrieved 2026-09-27T06:21:00.785Z
- europe-pmc · retrieved 2026-09-27T06:21:00.779Z
- hal · retrieved 2026-09-27T06:21:00.810Z